Murray AND Poole Enterprises Ltd
USPTO PatentsView assignee record - 19 granted patents across 2 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Murray ranks #15,473 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 2 technology areas.
- #15,473
- of 49,997 US assignees by volume
- 41st percentile
- by Innovation Score (32.3/100)
- 20.9
- avg claims per patent
- +160%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R15473 · Foreign Corporation #15,473 · 19 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 19 grants
- MID-PACK #15,473/49,997
- PHOTO-FINISH Madrigal Pharmaceuti…
- CPC-NARROW A61P · 2 areas
- INNOV-THIN 32.3/100
- CLAIMS-DENSE 20.9 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +160% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Madrigal Pharmaceuticals, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Murray’s 32.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Murray
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Murray AND Poole… · this assignee 32
Murray AND Poole… · this assignee
32 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Murray's Innovation Score is 32.3/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Murray?
Each dot is one of Murray’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Murray’s own 20.9 claims/patent is ABOVE the 15.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Murray's grants concentrate
Murray AND Poole Enterprises Ltd is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2017. By volume, Murray sits between Mocana Corporation and Make Ideas, LLC.
Murray's three-year grant acceleration
Murray AND Poole Enterprises Ltd shows 6 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Murray's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Mocana
Mocana Corporation
19 patents
- Moda-innochips
Moda-innochips Co., Ltd.
19 patents
- Morton Photonics…
Morton Photonics Incorporation
19 patents
- MSN Laboratories…
MSN Laboratories Private Limited
19 patents
- Madrigal Pharmace…
Madrigal Pharmaceuticals, Inc.
19 patents
- Magik Eye
Magik Eye Inc.
19 patents
- Magswitch Technol…
Magswitch Technology, Inc.
19 patents
- Make Ideas
Make Ideas, LLC
19 patents
- Murray AND Poole… ◀
Murray AND Poole Enterprises Ltd
19 patents
What this shows Murray holds 19 patents at rank #15,452, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Murray
By rank, the assignees closest to #15,452 in granted patent volume.
- Mocana Corporation #15,448 · 19 patents
- Moda-innochips Co., Ltd. #15,449 · 19 patents
- Morton Photonics Incorporation #15,450 · 19 patents
- MSN Laboratories Private Limited #15,451 · 19 patents
- Madrigal Pharmaceuticals, Inc. #15,453 · 19 patents
- Magik Eye Inc. #15,454 · 19 patents
- Magswitch Technology, Inc. #15,455 · 19 patents
- Make Ideas, LLC #15,456 · 19 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Murray's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Murray's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 41st percentile higher than 41% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 5.3% |
| 2018 | 2 | 10.5% |
| 2019 | 2 | 10.5% |
| 2020 | 3 | 15.8% |
| 2021 | 4 | 21.1% |
| 2022 | 1 | 5.3% |
| 2023 | 2 | 10.5% |
| 2024 | 3 | 15.8% |
| 2025partial year | 1 | 5.3% |
Which technologies does Murray AND Poole Enterprises Ltd patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Murray AND Poole Enterprises Ltd's patent record in context - here's where to go next.
- Murray AND Poole Enterprises Ltd's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #15,473 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Murray AND Poole Enterprises Ltd against Mocana Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 32.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.